Related Experiment Videos
[Liposarcoma of the retroperitoneal space].
Vestnik Khirurgii Imeni I. I. Grekova
|May 1, 1987
Summary
Retroperitoneal liposarcomas frequently recur, especially myxoid types. Complete surgical removal of recurrent tumors offers better long-term survival rates for these challenging liposarcomas.
Area of Science:
- Oncology
- Surgical Oncology
- Pathology
Context:
- Retroperitoneal liposarcomas are rare and often present in advanced stages.
- Surgical management is the primary treatment modality.
- Understanding recurrence patterns and survival outcomes is crucial for patient care.
Purpose:
- To analyze the clinical characteristics, treatment outcomes, and survival rates of patients with retroperitoneal liposarcomas.
- To identify factors associated with tumor recurrence and patient survival.
Summary:
- This study examined 60 patients (40-60 years old) with retroperitoneal liposarcomas, predominantly affecting women (62%).
- Operative treatment was performed in 96% of patients, with 82% undergoing radical surgery. Recurrence was observed in 66% of cases, most frequently in myxoid liposarcomas.
- Complete removal of recurrent tumors was achieved in 72% of cases. Five-year survival rates were 54.2% overall, with higher rates for myxoid (72.3%) versus polymorphocellular (23.1%) liposarcomas.
Impact:
- Findings highlight the high recurrence rate of retroperitoneal liposarcomas, particularly myxoid subtypes.
- Complete surgical resection of recurrent tumors is associated with improved survival.
- This data can inform treatment strategies and prognostication for retroperitoneal liposarcoma patients.